Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 5 (3) , 215-220
- https://doi.org/10.1016/0732-8893(86)90004-0
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Pulmonary Complications of the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1984
- Need to define colonial morphology of M. avium-intracellulare when reporting susceptibility test resultsTubercle, 1983
- Disseminated Mycobacterium Avium-intracellulare Infection in Homosexual Men with Acquired Cell-mediated Immunodeficiency: A Histologic and Immunologic Study of Two CasesAmerican Journal of Clinical Pathology, 1983
- In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complexAntimicrobial Agents and Chemotherapy, 1982
- Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?Antimicrobial Agents and Chemotherapy, 1981
- A Method for Testing for Synergy with Any Number of AgentsThe Journal of Infectious Diseases, 1978